Skip to main content
Clinical Trials/IRCT20240510061723N1
IRCT20240510061723N1
Recruiting
Phase 2

Investigating the effects of synbiotic supplementation on serum oxidative stress markers in systemic lupus erythematosus patients

Ardabil University of Medical Sciences0 sites76 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Systemic lupus erythematosus.
Sponsor
Ardabil University of Medical Sciences
Enrollment
76
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Definitive diagnosis of SLE
  • Age above 18 years

Exclusion Criteria

  • Taking antibiotics
  • breastfeeding
  • Uncontrolled blood pressure
  • Suffering from other autoimmune diseases
  • Severe kidney and liver disease
  • Life\-threatening SLE including lupus nephritis and CNS involvement
  • Lupus vasculitis
  • peritonitis
  • severe hemolysis
  • Platelets less than 40,000

Outcomes

Primary Outcomes

Not specified

Similar Trials